De Novo Post-Transplantation Malignancies: Incidence and Risk Factors

  • Jacques Dantal
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

An increased incidence of cancer in immunodeficient and immunosuppressed\break patients is now well established. Improvements in transplantation procedures and immunosuppressive therapies have resulted in better short-term and long-term graft survival, but immunosuppression exposes patients to long-term complications [1]. Malignancies are becoming the greatest limiting factor for patient and graft survival following kidney transplantation, even as incidence of death related to cardiovascular diseases and infections is decreasing [2]. Cancers are frequently more aggressive in transplant patients and are more likely to be fatal than would be expected in patients who have not undergone transplantation [3].


Renal Cell Carcinoma Transplant Recipient Renal Transplantation Kidney Transplantation Transplant Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342:605–612.CrossRefGoogle Scholar
  2. 2.
    ANZDATA. Australian and New Zealand Dialysis and Transplant Registry. 2006. Available at
  3. 3.
    Barrett W, First M, Aron B, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72:2186–2189.PubMedCrossRefGoogle Scholar
  4. 4.
  5. 5.
  6. 6.
    Dantal J, Hourmant M, Cantarovich D et al. Effect of long term immunosuppression in kidney graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623–628.PubMedCrossRefGoogle Scholar
  7. 7.
    Montagnino G, Lorca E, Tarantino A et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10:461–469.PubMedGoogle Scholar
  8. 8.
    Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29:831–833.PubMedCrossRefGoogle Scholar
  9. 9.
    Rinaldi M, Pellegrini C, D’Armini A et al. Neoplastic disease after heart transplantation: single center experience. Eur J Cardiothorac Surg. 2001; 19: 696–701.PubMedCrossRefGoogle Scholar
  10. 10.
    Buccianti G, Ravasi B, Cresseri D et al. Cancer in patients on renal replacement therapy in Lombardy, Italy. Lancet 1996; 347:59–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Adami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89:1221–1227.PubMedCrossRefGoogle Scholar
  12. 12.
    Pedotti P, Cardillo M, Rossini G et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 2003; 76:1448–1451.PubMedCrossRefGoogle Scholar
  13. 13.
    Andres A. Cancer incidences after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005; 56:71–85.PubMedCrossRefGoogle Scholar
  14. 14.
    Sheil AG. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31:1275–1279.CrossRefGoogle Scholar
  15. 15.
    Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905–913.PubMedCrossRefGoogle Scholar
  16. 16.
    Taylor D, Edwards L, Boucek M et al. Registry of the International Society of Heart and Lung Transplantation: Twenty second official adult heart transplanted report 2005. J Heart Lung Transplant 2005; 4:945–955.CrossRefGoogle Scholar
  17. 17.
    Ulrich C, Schmook T, Sachse M et al. Comparative epidemiology and pathogenic factors for non-melanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622–627.PubMedCrossRefGoogle Scholar
  18. 18.
    Euvrard S, Kanitakis J, Decullier E et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81:1093–1100.PubMedCrossRefGoogle Scholar
  19. 19.
    Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4:222–230.PubMedCrossRefGoogle Scholar
  20. 20.
    Oo Y, Gunson B, Lancashire R et al. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80:759–764.PubMedCrossRefGoogle Scholar
  21. 21.
    Sheiner P, Magliocca J, Bodian C et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69:781–789.PubMedCrossRefGoogle Scholar
  22. 22.
    Haagasma E, Hagens V, Schaapveld M et al. Increased cancer risk after liver transplantation: a population-based study. Hepatology 2001; 34:161–164.Google Scholar
  23. 23.
    Penn I. Post transplant malignancies; the role of immunosuppression. Clin Transplant 1998; 1:147–158.Google Scholar
  24. 24.
    Penn I. Post transplantation malignancies. Transplant Proc 1999; 31:1260–1262.PubMedCrossRefGoogle Scholar
  25. 25.
    Birkeland S, Storm H, Lamm L et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995; 60:183–189.PubMedCrossRefGoogle Scholar
  26. 26.
    Sheil A. Cancer in dialysis and transplanted patients. In: Morris JP (ed) Kidney Transplantation Principles. Philadelphia: Saunders, 2001:558–570.Google Scholar
  27. 27.
    Port F, Ragheb N, Schwartz A et al. Neoplasms in dialysis patients: a population based study. Am J Kidney Dis 1989; 14:119–123.PubMedGoogle Scholar
  28. 28.
    Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end stage renal disease: an international collaborative study. Lancet 1999; 354:93–99.PubMedCrossRefGoogle Scholar
  29. 29.
    Vajdic C, McDonald S, McCredie et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296:2823–2831.PubMedCrossRefGoogle Scholar
  30. 30.
    Kessler M, Jay N, Guillemon F. Excess risk of cancer in renal transplant patients. Transplant Int 2006; 19:908–914.CrossRefGoogle Scholar
  31. 31.
    Potaris K, Radovancevic B, Thomas C et al. Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg 2005; 79:980–983.PubMedCrossRefGoogle Scholar
  32. 32.
    Goldstein DJ, Austin JH, Zuech N et al. Carcinoma of the lung after heart transplantation. Transplantation 1996; 62:772–775.PubMedCrossRefGoogle Scholar
  33. 33.
    Rinaldi M, Pellegrini C, D’Armini A et al Neoplastic disease after heart transplantation: single center experience. Eur J Cardiothorac Surg 2001; 19:696–701.PubMedCrossRefGoogle Scholar
  34. 34.
    Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12:S328–S336.PubMedGoogle Scholar
  35. 35.
    Rosenbaum DH, Bhojani RA, Dikmen E et al. Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. J Heart Lung Transplant 2005; 24:2043–2047.PubMedCrossRefGoogle Scholar
  36. 36.
    Fabia R, Levy M, Testa G et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998 ; 176:265–269.PubMedCrossRefGoogle Scholar
  37. 37.
    Dvorchik I, Subotin M, Demetris A et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002; 35:380–384.PubMedCrossRefGoogle Scholar
  38. 38.
    Sanchez EQ, Marubashi S, Jung G et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transplant 2002; 8:285–291.CrossRefGoogle Scholar
  39. 39.
    Briceno J, Lopez-Cillero P, Fraga E, Pera C. Results of liver transplantation in a Spanish group: a report from the Cordoba unit. Clin Transplant 2001; 2:187–194.Google Scholar
  40. 40.
    Duvoux C, Delacroix I, Richardet JP et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67:418–421.PubMedCrossRefGoogle Scholar
  41. 41.
    Fung J, Jain A, Kwak E et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transplant 2001; 7:S109–S118.CrossRefGoogle Scholar
  42. 42.
    Aroldi A, Lampertico P, Montagnino G et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005; 79:1132–1136.PubMedCrossRefGoogle Scholar
  43. 43.
    Kelly DM, Emre S, Guy SR et al. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83:1237–1243.PubMedCrossRefGoogle Scholar
  44. 44.
    Benlloch S, Berenguer M, Prieto M et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4:596–604.PubMedCrossRefGoogle Scholar
  45. 45.
    Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant recipients. Transplantation 1999; 68:1859–1864.PubMedCrossRefGoogle Scholar
  46. 46.
    Muller AM, Ihorst G, Mertelsmann R et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84:1–12.PubMedCrossRefGoogle Scholar
  47. 47.
    Rezaee SA, Cunningham C, Davison AJ et al. Kaposi’s sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol 2006; 87:1781–1804.PubMedCrossRefGoogle Scholar
  48. 48.
    Majewski S, Jablonska S. Current views on the role of human papillomaviruses in cutaneous oncogenesis. Int J Dermatol 2006; 45:192–196.PubMedCrossRefGoogle Scholar
  49. 49.
    Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127:S56–S61.PubMedCrossRefGoogle Scholar
  50. 50.
    Swinnen L, Costanzo-Nordin M, Fisher S et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323:1723–1728.PubMedGoogle Scholar
  51. 51.
    Wilkinson A, Smith J, Hunsicker L et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989; 47:293–296.PubMedCrossRefGoogle Scholar
  52. 52.
    Kliem V, Kolditz M, Behrend M et al. Risk of renal cell carcinoma after kidney transplantation. Clin Transplant 1997; 11:255–258.PubMedGoogle Scholar
  53. 53.
    Wu M, Lian J, Yang C et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 2004; 43:1091–1097.PubMedCrossRefGoogle Scholar
  54. 54.
    Goldfarb D, Neumann H, Penn I. Results of renal transplantation in patients with renal cell carcinoma and von Hippel–Lindau disease. Transplantation 1997; 64:1726–1729.PubMedCrossRefGoogle Scholar
  55. 55.
    Cleper R, Davidovitz M, Krause I et al. Unexpected Wilms’ tumor in a pediatric renal transplant recipient: suspected Denys–Drash syndrome. Transplant Proc 1999; 31:1907–1909.PubMedCrossRefGoogle Scholar
  56. 56.
    Gomez E, Portal CG, Seco MA, Alvarez-Grande J. Multiple solid malignancies in a renal transplant patient. Nephrol Dial Transplant 1999; 14:803–804.PubMedCrossRefGoogle Scholar
  57. 57.
    Barroso-Vicens E, Ramirez G, Rabb H. Multiple primary malignancies in a renal transplant patient. Transplantation 1996; 61:1655–1666.PubMedCrossRefGoogle Scholar
  58. 58.
    Nagele H, Kalmar P, Rodiger W, Stubbe HM. Smoking after heart transplantation: an underestimated hazard? Eur J Cardiothorac Surg 1997; 12:70–74.PubMedCrossRefGoogle Scholar
  59. 59.
    Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004; 31:726–733.PubMedCrossRefGoogle Scholar
  60. 60.
    Lipworth L, Tarone R, McLaughlin J. The epidemiology of renal cell carcinoma. J Urol 2006; 176:2353–2358.PubMedCrossRefGoogle Scholar
  61. 61.
    Pelucchi C, Bosetti C, Negri E at al. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 2006; 3:327–340.PubMedCrossRefGoogle Scholar
  62. 62.
    Qiu D, Kurosawa M, Lin Y et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 2005; 1:S157–167.CrossRefGoogle Scholar
  63. 63.
    Moore TO, Moore AY, Carrasco D, Vander Straten M, Arany I, Au W, Tyring SK. Human papillomavirus, smoking, and cancer. J Cutan Med Surg 2001; 5:323–328.PubMedCrossRefGoogle Scholar
  64. 64.
    Ramsay H, Fryer A, Hawley CM et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397–406.PubMedCrossRefGoogle Scholar
  65. 65.
    Hoshida Y, Tsukuma H, Yasunaga Y et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71:517–520.PubMedCrossRefGoogle Scholar
  66. 66.
    Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathol Int 2004; 54:649–658.PubMedCrossRefGoogle Scholar
  67. 67.
    67. Feng WW, Wang TN, Chen HC et al. Malignancies after renal transplantation in southern Taiwan: experience in one centre. BJU Int 2006; 97.Google Scholar
  68. 68.
    Alzahrani A, El-Harith el-H, Milzer J et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005; 20:2532–2536.PubMedCrossRefGoogle Scholar
  69. 69.
    Girndt M, Kohler H. Waiting time for patients with history of malignant disease before listing for organ transplantation. Transplantation 2005; 80:S167–S170.PubMedCrossRefGoogle Scholar
  70. 70.
    Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 1997; 2:14–17.PubMedGoogle Scholar
  71. 71.
    Taioli E, Piselli P, Arbustini E et al. Incidence of second primary cancer in transplanted patients. Transplantation 2006; 81:982–985.PubMedCrossRefGoogle Scholar
  72. 72.
    Demeter J, Lehoczky D. Splenectomy and the risk of developing leukemia. J Clin Oncol 1993; 11:2287.PubMedGoogle Scholar
  73. 73.
    Mellemkjoer L, Olsen J, Linet M et al. Cancer risk after splenectomy. Cancer 1995; 75:577–583.PubMedCrossRefGoogle Scholar
  74. 74.
    Linet MS, Nyren O, Gridley G et al. Risk of cancer following splenectomy. Int J Cancer 1996; 66:611–616.PubMedCrossRefGoogle Scholar
  75. 75.
    Birkeland S, Lokkegaard H, Storm H, et al. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355:1886–1887.PubMedCrossRefGoogle Scholar
  76. 76.
    Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25:1297–1301.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jacques Dantal
    • 1
  1. 1.Department of Nephrology and Clinical ImmunologyUniversity Hospital Hôtel DieuFrance

Personalised recommendations